116 related articles for article (PubMed ID: 37164111)
1. Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population.
Seo YG; Polyzos SA; Park KH; Mantzoros CS
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3322-3335. PubMed ID: 37164111
[TBL] [Abstract][Full Text] [Related]
2. The Association between Advanced Liver Fibrosis and Mortality Is Modified by Dietary Quality among Korean Adults: Results from the Korea National Health and Nutrition Examination Survey with Mortality Data.
Lee J; Jo G; Park D; Jun HJ; Bae JH; Shin MJ
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986234
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
Hwang YC; Ahn HY; Park SW; Park CY
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999-2016.
Golabi P; Paik JM; Harring M; Younossi E; Kabbara K; Younossi ZM
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2838-2847.e7. PubMed ID: 34929391
[TBL] [Abstract][Full Text] [Related]
5. The association of hepatic steatosis and fibrosis with heart failure and mortality.
Park J; Kim G; Kim H; Lee J; Lee YB; Jin SM; Hur KY; Kim JH
Cardiovasc Diabetol; 2021 Sep; 20(1):197. PubMed ID: 34583706
[TBL] [Abstract][Full Text] [Related]
6. Associations of Serum Uric Acid Level With Liver Enzymes, Nonalcoholic Fatty Liver Disease, and Liver Fibrosis in Korean Men and Women: A Cross-Sectional Study Using Nationally Representative Data.
Lee JM; Kim HW; Heo SY; Do KY; Lee JD; Han SK; Baik SK; Kim MY; Chang SJ
J Korean Med Sci; 2023 Aug; 38(34):e267. PubMed ID: 37644682
[TBL] [Abstract][Full Text] [Related]
7. Liver fibrosis scores predict liver disease mortality in the United States population.
Unalp-Arida A; Ruhl CE
Hepatology; 2017 Jul; 66(1):84-95. PubMed ID: 28195363
[TBL] [Abstract][Full Text] [Related]
8. Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack.
Baik M; Nam HS; Heo JH; Park HJ; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Lee HS; Kim SU; Kim YD
Cerebrovasc Dis; 2020; 49(5):474-480. PubMed ID: 32980849
[TBL] [Abstract][Full Text] [Related]
9. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study.
Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
Cardiovasc Diabetol; 2022 Apr; 21(1):53. PubMed ID: 35429980
[TBL] [Abstract][Full Text] [Related]
10. Association of liver fibrosis biomarkers with overall and CVD mortality in the Korean population: The Dong-gu study.
Choi SW; Kweon SS; Lee YH; Ryu SY; Nam HS; Shin MH
PLoS One; 2022; 17(12):e0277729. PubMed ID: 36512564
[TBL] [Abstract][Full Text] [Related]
11. Food Insecurity is Associated With Mortality Among U.S. Adults With Nonalcoholic Fatty Liver Disease and Advanced Fibrosis.
Kardashian A; Dodge JL; Terrault NA
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2790-2799.e4. PubMed ID: 34958747
[TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitudinal cohort study.
Anstee QM; Berentzen TL; Nitze LM; Jara M; Jensen AB; Kjær MS; Mangla KK; Tarp JM; Khunti K
Lancet Reg Health Eur; 2024 Jan; 36():100780. PubMed ID: 38188279
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
[TBL] [Abstract][Full Text] [Related]
14. Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study.
Chang Y; Cho YK; Cho J; Jung HS; Yun KE; Ahn J; Sohn CI; Shin H; Ryu S
Am J Gastroenterol; 2019 Apr; 114(4):620-629. PubMed ID: 30694866
[TBL] [Abstract][Full Text] [Related]
15. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.
Hydes TJ; Kennedy OJ; Buchanan R; Cuthbertson DJ; Parkes J; Fraser SDS; Roderick P
BMC Med; 2023 May; 21(1):185. PubMed ID: 37198624
[TBL] [Abstract][Full Text] [Related]
16. Liver Fibrosis Marker and Postoperative Mortality in Patients Without Overt Liver Disease.
Zelber-Sagi S; O'Reilly-Shah VN; Fong C; Ivancovsky-Wajcman D; Reed MJ; Bentov I
Anesth Analg; 2022 Nov; 135(5):957-966. PubMed ID: 35417420
[TBL] [Abstract][Full Text] [Related]
17. Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk.
Delgado GE; Kleber ME; Moissl AP; Yazdani B; Kusnik A; Ebert MP; März W; Krämer BK; Lammert A; Teufel A
Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G252-G261. PubMed ID: 34132110
[TBL] [Abstract][Full Text] [Related]
18. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
20. Positive hepatitis B core antibody is associated with advanced fibrosis and mortality in nonalcoholic fatty liver disease.
Zhang P; Liu Z; Fan H; Shi T; Han X; Suo C; Chen X; Zhang T
Eur J Gastroenterol Hepatol; 2023 Mar; 35(3):294-301. PubMed ID: 36708301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
